Chronic inducible urticaria (CIU) is a a challenging dermatological disorder characterized by frequent hives triggered by specific stimuli. The global market for CIU therapies is anticipated to witness rapid expansion over the foreseeable few years, driven by influences such as rising prevalence of CIU, improved diagnostic capabilities, and innovat